Emergency Operations for Bleeding Duodenal Ulcer:A simple option to consider: Case Report by El Shallaly, GEHA et al.
 
© Sudan JMS Vol. 3, No. 4, Dec.2008                   339 
 
Vtáx exÑÉÜà
Emergency Operations for Bleeding Duodenal Ulcer:A simple option to 
consider: Case Report 
Gamal E H A El Shallaly, Eltayeb A Ali, Suzan Salih 
Abstract 
       We report a 46 years-old man who had severe bleeding from a posterior 
duodenal ulcer (DU) that was diagnosed but could not be treated endoscopically 
in another health facility.  He went into shock as he was being admitted to the 
casualty at Khartoum North Teaching Hospital (KNTH). His haemoglobin (Hb) 
dropped to five gram/dl. He required resuscitation and transfusion of six units of 
blood overnight. Emergency surgery was performed.  
Over sewing (OS) of the ulcer was done and the stenosed first part of duodenum was closed 
transversely (pyloroplasty). No acid-reducing procedure (ARP) was done. The patient received anti-
helicobacter therapy via the intravenous route preoperatively and continued postoperatively. This 
was later given orally after he started taking by mouth. He made an uneventful recovery with no 
recurrence of bleeding and was discharged home one week latter. Endoscopy was done at KNTH 
six weeks later. This showed complete healing of the ulcer with no evidence of Helicobacter pylori 
in the biopsies taken. 
         We found simple OS of the bleeding DU together with anti-helicobacter therapy safe, 
efficient, and not associated with re-bleeding. We discuss the rationale of this simple treatment. We 
propose the need for a randomized controlled study comparing it with acid-reducing procedure 
(ARP) as options in the surgical treatment of bleeding DU. 
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 46-year old male presented to the 
University unit in the casualty at 
Khartoum North Teaching Hospital 
(KNTH) with haematemesis and melaena for 
two days. This was preceded two days before 
with dizziness and general fatigue. The 
patient was a heavy smoker (30 cigarettes a 
day) for many years. He admitted to taking 
Aspirin for headache. 
Upper Gastrointestinal (GI) endoscopy was 
performed at another health facility. This 
showed an ulcer in the posterior wall of the 
first part of the duodenum, covered with a 
blood clot. 
 It was also reported that the ulcer was not 
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injected, and surgical treatment was 
recommended if bleeding recurred. 
Afterwards, the patient unfortunately had a 
recurrent bleed and slipped into a 
hypovolaemic shock when he presented to our 
casualty. He was admitted to the ICU for 
resuscitation. This consisted of intravenous 
(IV) fluid and blood transfusion. He was also 
given Cimetidine 200 mg i.v. 8 hourly and 
antibiotics (cephalosporin, metronidazole, and 
amoxicillin). 
         His initial investigations showed 
haemoglobin (Hb) of Five (5) gm/dl. The 
patient received six units of blood during the 
night and the following morning, after which 
his Hb increased to 11gm/dl. He was taken to 
theatre where laparotomy was done. Dense 
adhesions were found in the supracolic 
compartment, between the greater omentum, 
duodenum, gallbladder, and liver. The 
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adhesions were released. The first part of the 
duodenum was stenosed and indurated. 
Kocherisation of the duodenum was done, 
and a longitudinal incision was made along 
the pylorus and the first part of the 
duodenum. The posterior ulcer was identified. 
There was no active bleeding, but a vessel 
was seen in the floor of the ulcer. This was 
over sewn with No. 2/0 Vicryl sutures. The 
pyloric incision was sutured in 2 layers 
transversely as a pyloroplasty using 2/0 vicryl 
as well. Vagotomy was not done. 
         The patient had a smooth uneventful 
postoperative recovery and was discharged 
home after one week. He received anti-
helicobacter quadruple therapy orally 
consisting of Amoxicillin 500 mg 8-hourly, 
Metronidazole 500 mg 8-hourly, and 
Clarithromycin 500 mg twice a day, for 14 
days. In addition, he had Omeprazole 20 mg 
bd for 4 weeks. 
         The patient underwent upper GI 
endoscopy 6 weeks after his discharge. This 
revealed complete healing of the ulcer, and 
prepyloric biopsies did not show evidence of 
Helicobacter. He remains asymptomatic 18 
months after discharge. 
Discussion 
         Bleeding and perforated DU have the 
same aetiology and pathogenesis. They differ 
only in the duodenal site of the pathology. 
The former erodes the duodenal wall 
posteriorly into the gastro-duodenal artery, 
and the latter erodes anteriorly into the 
peritoneal cavity. Both ulcers may occur 
simultaneously or at different times in the 
same patient. The finding of dense adhesions 
anterior to the duodenum in this patient may 
indicate the occurrence of a silent perforation 
some time earlier.  
         The other difference between bleeding 
and perforated DU is in their current surgical 
treatment strategies. Whereas the 
management options of perforated DU have 
been reviewed from time to time particularly 
in the post-Helicobacter era, those of bleeding 
peptic ulcer remained largely the same. At 
one point of time, the standard treatment of 
perforated DU consisted of over- sewing the 
perforation together with an acid-reducing 
procedure (ARP), such as truncal vagotomy 
(TV). This necessitated addition of a drainage 
procedure, such as pyloroplasty or gastro-
enterostomy because TV would not only 
inhibit gastric acid secretion but also the 
motility of the gut. As time went by, less 
radical ARPs were developed such as 
selective and highly selective vagotomy 
whereby the vagal motor branches (Nerves of 
Latarjet) to the pyloric area were preserved. 
Eventually, with the discovery of 
Helicobacter pylori as a major cause of DU 
and the development of efficient anti-
helicobacter therapy, ARPs are rarely 
performed nowadays for perforated DU. 
Moreover, non-operative management is now 
an established option as part of the 
management of perforated DU in selected 
cases. 
         In contrast to perforated DU, the 
management of bleeding complications has 
not changed much in the post-Helicobacter 
era, and is still widely variable and radical. 
This may be due to the fact that bleeding DU 
has a more dramatic presentation and carries a 
more serious risk of death from 
exsanguinations and hence surgeons are still 
carrying out radical surgery.  
          The indications of surgery in bleeding 
DU that has been mostly agreed upon are, age 
of 60 years or above, recurrent bleeding 
during the same hospital admission and the 
need to transfuse more than half the volume 
of the patient blood (5-6 units) to maintain a 
haemodynamic stable state, and Hb of 10 
gm/dl at least. 
         The best surgical procedure for treating 
bleeding duodenal ulcer is unknown. Reuben 
from the USA reported wide variations in the 
management of bleeding DU that depended 
on the surgeon’s experience and individual 
patient’s factors1. The surgical options 
include: (i) over sewing (OS) of the bleeding 
ulcer plus an acid-reducing procedure (ARP), 
such as TV and pyloroplasty (ii) gastric 
resection (GR) with ulcer excision. Gastric 
resection (GR) includes operations such as 
Billroth II with gastro-jejunal anastomosis, or 
antrectomy and vagotomy. All these 
procedures are characterized by a long 
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operative/ anaesthetic time, and each carries 
significant risks and life-long side effects. 
           Comparative studies showed that the 
recurrence rate for bleeding is higher in OS + 
truncal vagotomy (17%), than GR (3%), 
whereas the anastomotic leak rate is lower in 
OS +TV (3%) than GR (13%)2. However, 
some studies had either small number of 
patients or were stopped because of slow 
recruitment.  
          The surgical options in bleeding DU 
depend on the patient condition, the expertise 
of the surgeon1, and the size of the ulcer3. 
Some authors suggest that GR would be the 
operation of choice for (giant) ulcers of two 
cm or more in internal diameter3.    
           We believe that the discovery of 
Helicobacter pylori and the development of 
efficient anti-helicobacter therapy should also 
change the treatment options of bleeding DU 
as it did for perforated DU. 
           Gisbert et al have shown that the 
incidence of H. pylori infection in DU 
bleeding is almost 100% and that after H. 
pylori eradication there was no recurrence of 
bleeding after one year4. The H. pylori re-
infection rate was <3% after one year. It was 
also shown that maintenance therapy with H2 
blockers or proton pump inhibitors was not 
necessary after eradication of H pylori.           
Another study has shown that Helicobacter 
eradication therapy has reduced ulcer relapse 
rate in patients who had perforated DU 
treated by simple OS to < 5% after one year5. 
           Our patient received intravenous anti-
helicobacter therapy on admission. 
Emergency surgery was indicated to stop the 
bleeding as he presented in shock and we 
didn't have emergency endoscopic services at 
the time. The patient recovery was smooth. 
Oral anti-helicobacter therapy was continued 
when the patient started to take oral fluids on 
the 3rd postoperative day. The patient was 
given some health education and advised to 
stop smoking. He was followed up in our 
outpatient clinic. Six weeks after discharge 
from the hospital he underwent a check upper 
GI endoscopy at KNTH. This showed 
complete healing of the ulcer. Pre-pyloric 
biopsies showed no evidence of Helicobacter 
pylori. The patient continued to be well with 
no recurrence of bleeding 18 months after the 
operation. 
          We agree with Milat, et al6 that 
randomized controlled studies are needed to 
compare ARPs with minimal surgery 
(stopping bleeding) combined with 
antisecretory drugs and eradication of 
Helicobacter pylori. These studies may be 
difficult to carry out due to the small numbers 
of such patients. 
Conclusion 
          This case showed that, simple over 
sewing of bleeding duodenal ulcer combined 
with anti-helicobacter therapy is safe, and 
efficient. It was not associated with re-
bleeding with long-term follow up. This case 
also highlighted the need to include this 
simple procedure in randomised controlled 
studies to compare it with the radical acid-
reducing procedures that were developed 
prior to the Helicobacter era. 
Note: 
The abstract of this paper was presented as a 
poster at the 15th International Congress of the 
European Association for Endoscopic 
Surgeons (EAES), Athens, Greece 4-7 July 
2007. 
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